Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE
Among people with ASCVD and COPD/asthma, there were no significant differences in ASCVD outcomes based on aspirin dosing except stroke. Further evaluation of stroke prevention in this population is warranted.
Authors
- Ashraf Fawzy (ORCID: https://orcid.org/0000-0002-6089-366X)
- W. Schuyler Jones (ORCID: https://orcid.org/0000-0002-7288-9596)
- Amanda Stebbins (ORCID: https://orcid.org/0000-0002-0808-9025)
- Sunil B. Kripalani (ORCID: https://orcid.org/0000-0002-4214-7129)
- Adrian F. Hernandez (ORCID: https://orcid.org/0000-0003-3387-9616)
- Kamal Gupta (ORCID: https://orcid.org/0000-0002-2440-9033)
- Lisa Wruck (ORCID: https://orcid.org/0000-0003-1732-9067)
- Mark T. Dransfield (ORCID: https://orcid.org/0000-0002-9207-1820)
- Christopher L. Mosher (ORCID: https://orcid.org/0000-0002-8463-1947)
- Russell L. Rothman (ORCID: https://orcid.org/0000-0002-1506-3990)
- Jeff Whittle (ORCID: https://orcid.org/0000-0002-9544-838X)
- Catherine P. Benziger (ORCID: https://orcid.org/0000-0002-8992-6197)
- C. Lamberton
- Ken M. Kunisaki (ORCID: https://orcid.org/0000-0001-8644-2827)
Institutions
- Essentia Health (US)
- Johns Hopkins University (US)
- Duke University (US)
- Johns Hopkins Medicine (US)
- University of Minnesota System (US)
- University of Alabama at Birmingham (US)
- Clinical Research Institute (US)
- Milwaukee VA Medical Center (US)
- Minneapolis VA Health Care System (US)
- Pulmonary and Allergy Associates (US)
- University of Kansas Medical Center (US)
- University of Minnesota Medical Center (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1161/jaha.125.043161
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00